Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%

Clinical trial NCT07215962 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07215962
Sponsor: Bristol-Myers Squibb
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2024-11-22
Primary completion: 2025-07-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.